Detalles de la búsqueda
1.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129464
2.
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
JAMA
; 327(24): 2413-2422, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35661856
3.
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Cancer
; 127(13): 2251-2261, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826754
4.
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?
Oncologist
; 24(11): e1148-e1155, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036771
5.
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
Support Care Cancer
; 27(10): 3869-3875, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30767130
6.
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Cancer
; 124(3): 537-545, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29044496
7.
Neoadjuvant systemic therapy for regionally advanced melanoma.
J Surg Oncol
; 117(6): 1164-1169, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29228467
8.
Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors.
Curr Oncol Rep
; 20(3): 24, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29511902
9.
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).
Psychooncology
; 25(4): 441-6, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994447
10.
Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy.
Am J Hematol
; 96(10): E362-E367, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34137072
11.
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
Support Care Cancer
; 24(6): 2661-7, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26768436
12.
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).
Cancer
; 120(22): 3575-83, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043153
13.
The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma.
Dermatol Ther
; 32(2): e12813, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30620137
14.
Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy.
J Immunother Precis Oncol
; 7(2): 126-129, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721405
15.
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
Immunotherapy
; 16(1): 29-42, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937397
16.
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.
JCO Clin Cancer Inform
; 8: e2300151, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38687915
17.
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
J Immunother Precis Oncol
; 7(1): 1-6, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38327758
18.
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.
JCO Oncol Pract
; 20(2): 239-246, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175992
19.
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
Clin Cancer Res
; 30(12): 2623-2635, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530846
20.
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Nat Commun
; 15(1): 1430, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365756